Literature DB >> 12975102

[Prevalence of cancer in the Guadalajara health area].

J M Alonso Gordo1, A Bárcena Marugán, D Jiménez Del Val, J J Palacios Rojo, C Royo Sánchez, J Urbina Torija.   

Abstract

OBJECTIVE: To quantify the prevalence of cancerand its distribution in adults.
DESIGN: Descriptive study of point prevalence through research into primary and secondary sources.
SETTING: Primary care, Guadalajara Health Region. 133 539 people over 14 years old. PARTICIPANTS: Patients previously diagnosed with cancer, who had a health card in the health area in June 1999. MEASUREMENTS: Demographic and diagnostic details (location according to CIE-9, date and diagnostic method). DATA SOURCES: primary care clinical records, cancer morbidity records and attendance orders. Overall crude and adjusted rates, in function of sex and age group, and specific to locations, were calculated. They were compared with data from other studies and data calculated for Spain on the basis of WHO information.
RESULTS: 2717 tumours (2595 patients). Mean age, 68.2 (95% CI, 67.6-68.7); diagnostic age, 62.8 (95% CI, 62.1-63.5), in both cases higher in men (P<.01). Most common tumours: prostate, bladder, colon and lung (men); breast, colon, endometrium and ovaries (women). Crude prevalence: men, 2303.8/100 000; women, 1763.8. Adjusted to world population: 1394.2 and 1227.4/100 000, respectively (prevalence ratio, 1.14; 95% CI, 1.03-1.25). Truncated rate higher in women than in men (1638/100 000 against 1308). Five-year period with highest prevalence: 75-79 years old in men (8763.5/100 000) and 80-84 in women (4558.7/100 000).
CONCLUSIONS: Cancer prevalence in adults is slightly above 2%. Once adjusted for age, values are similar to other studies and as expected for our country. The most common tumours are in the digestive apparatus, breast and the genito-urinary system. The man/woman proportion is higher than that described in other studies.

Entities:  

Mesh:

Year:  2003        PMID: 12975102      PMCID: PMC7681869          DOI: 10.1016/s0212-6567(03)79237-3

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  27 in total

1.  [Use of population based registries in developing a regional medical program against cancer. Example of the Rhone-Alpes region].

Authors:  F Ménégoz; M F Véran-Peyret
Journal:  Rev Epidemiol Sante Publique       Date:  1996       Impact factor: 1.019

2.  Estimating the prevalence of cancer in the United States.

Authors:  A P Polednak
Journal:  Cancer       Date:  1997-07-01       Impact factor: 6.860

3.  Reliability of cancer registration data.

Authors:  C A Stiller
Journal:  Eur J Cancer       Date:  1997-05       Impact factor: 9.162

4.  Estimated point prevalence of cancer in Japan.

Authors:  K Aoki; H Kobayashi; Y Ohno; R Sasaki; H Yanagawa
Journal:  Natl Cancer Inst Monogr       Date:  1982

5.  Incidence and prevalence of all cancerous diseases in Italy: trends and implications.

Authors:  A Verdecchia; A Mariotto; R Capocaccia; G Gatta; A Micheli; M Sant; F Berrino
Journal:  Eur J Cancer       Date:  2001-06       Impact factor: 9.162

6.  Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey.

Authors:  M Hewitt; N Breen; S Devesa
Journal:  J Natl Cancer Inst       Date:  1999-09-01       Impact factor: 13.506

7.  Cancer prevalence in European registry areas.

Authors:  A Micheli; E Mugno; V Krogh; M J Quinn; M Coleman; T Hakulinen; G Gatta; F Berrino; R Capocaccia
Journal:  Ann Oncol       Date:  2002-06       Impact factor: 32.976

8.  The prevalence of cancer among adults in the United States: 1987.

Authors:  J Byrne; L G Kessler; S S Devesa
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

9.  Estimating completeness of cancer registration in Saarland/Germany with capture-recapture methods.

Authors:  H Brenner; C Stegmaier; H Ziegler
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  Cancer prevalence in Italian regions with local cancer registries.

Authors:  A Mariotto; L G Dally; A Micheli; F Canario; A Verdecchia
Journal:  Tumori       Date:  1999 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.